|

VIP943 (QW) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Vincerx Pharma, Inc.1

Indications

  • High-risk Myelodysplastic Syndrome1
  • B-cell Acute Lymphoblastic Leukemia1
  • Acute Myeloid Leukemia1
  • Cancer1

Birmingham, Alabama1 trial

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

University of Alabama at Birmingham

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.